These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
34. [Perspectives in immunotherapy of Alzheimer's disease]. Rossi G Recenti Prog Med; 2003; 94(7-8):305-8. PubMed ID: 12868235 [TBL] [Abstract][Full Text] [Related]
35. Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." A proposal to increase participation in Alzheimer's disease clinical trials. Ryan JM; Schneider G; Jacobsen JS Alzheimers Dement; 2009 Mar; 5(2):140-2. PubMed ID: 19328445 [No Abstract] [Full Text] [Related]
36. Potential roles of digital technologies in clinical trials. Czaja S; Gold M; Bain LJ; Hendrix JA; Carrillo MC Alzheimers Dement; 2017 Sep; 13(9):1075-1076. PubMed ID: 28870374 [No Abstract] [Full Text] [Related]
37. Clinical Trials for Disease-Modifying Therapies in Alzheimer's Disease: A Primer, Lessons Learned, and a Blueprint for the Future. Cummings J; Ritter A; Zhong K J Alzheimers Dis; 2018; 64(s1):S3-S22. PubMed ID: 29562511 [TBL] [Abstract][Full Text] [Related]
38. What We Learn from the CTAD (Clinical Trials Alzheimer's Disease) 2018. Vellas B; Aisen P; Weiner M; Touchon J J Prev Alzheimers Dis; 2018; 5(4):214-215. PubMed ID: 30298178 [No Abstract] [Full Text] [Related]
39. The clinical interface of depression and dementia. Raskind MA J Clin Psychiatry; 1998; 59 Suppl 10():9-12. PubMed ID: 9720476 [TBL] [Abstract][Full Text] [Related]